[{"arm_notes": "", "treatment_id": null, "treatment_name": "TODO PlaceboControl group: single dose of normal saline (0.9% sodium chloride solution for injection), (0.25 or 0.5 ml) on day 1, which is received intramuscularly (deltoid muscle).", "treatment_type": "TODO", "pharmacological_treatment": "Placebo"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO PreventionIntervention group 1: a single dose of 50 \u03bcg/0.5 ml of COReNAPCIN vaccine (Produced by ReNAP Co.) on day 1, which is received intramuscularly (deltoid muscle). COReNAPCIN is an mRNA vaccine encapsulated by lipid nanoparticles (LNP), containing mRNA encoding the spike protein of the SARS-CoV-2 virus.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO PreventionIntervention group 1: a single dose of 25 \u03bcg/0.25 ml of COReNAPCIN vaccine (Produced by ReNAP Co.) on day 1, which is received intramuscularly (deltoid muscle). COReNAPCIN is an mRNA vaccine encapsulated by lipid nanoparticles (LNP), containing mRNA encoding the spike protein of the SARS-CoV-2 virus.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "25 \u03bcg", "treatment_id": 2689, "treatment_name": "Corenapcin vaccine", "treatment_type": "Rna based vaccine", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "50 \u03bcg", "treatment_id": 2689, "treatment_name": "Corenapcin vaccine", "treatment_type": "Rna based vaccine", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]